South Dakota Investment Council Sells 37,921 Shares of Humana Inc. $HUM

South Dakota Investment Council lowered its stake in Humana Inc. (NYSE:HUM – Free Report) by 48.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,975 shares of the insurance provider’s stock after selling 37,921 shares during the quarter. South Dakota Investment Council’s holdings in Humana were worth $15,635,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of HUM. Johnson Financial Group Inc. purchased a new stake in Humana during the second quarter valued at about $26,000. Trust Co. of Vermont purchased a new position in shares of Humana in the second quarter worth approximately $28,000. Bogart Wealth LLC raised its holdings in shares of Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 48 shares during the period. MidFirst Bank purchased a new stake in shares of Humana in the 2nd quarter valued at approximately $35,000. Finally, Highland Investment Advisors LLC purchased a new stake in shares of Humana in the 2nd quarter valued at approximately $43,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on HUM. Truist Financial raised their price objective on shares of Humana from $415.00 to $475.00 and gave the stock a “hold” rating in a research note on Monday, October 12th. Zacks Research raised shares of Humana from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, November 10th. Leerink Partners upgraded Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price for the company in a report on Thursday, July 30th. Barclays raised their target price on Humana from $582.00 to $587.00 and gave the stock an “overweight” rating in a research report on Monday, November 9th. Finally, Piper Sandler raised their target price on Humana from $463.00 to $526.00 and gave the stock an “overweight” rating in a research report on Monday, November 9th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $484.78.

Check Out Our Latest Analysis on HUM

Insider Activity

In other Humana news, insider Joseph Ventura sold 5,495 shares of Humana stock in a transaction on Monday, November 9th. The shares were sold at an average price of $433.85, for a total transaction of $2,384,005.75. Following the completion of the sale, the insider owned 21,910 shares of the company’s stock, valued at $9,505,653.50. This trade represents a 20.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 0.20% of the stock is owned by company insiders.

Humana Price Performance

Shares of HUM opened at $442.84 on Wednesday. The business’s 50-day moving average is $410.55 and its 200-day moving average is $319.48. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.65 and a quick ratio of 1.65. The company has a market capitalization of $53.19 billion, a price-to-earnings ratio of 43.08, a P/E/G ratio of 2.20 and a beta of 0.65. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $462.87.

Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings results on Friday, November 6th. The insurance provider reported ($0.70) EPS for the quarter, topping the consensus estimate of ($1.00) by $0.30. Humana had a net margin of 0.81% and a return on equity of 8.50%. The business had revenue of $41.16 billion during the quarter, compared to analysts’ expectations of $40.87 billion. During the same period last year, the company posted $3.24 earnings per share. The firm’s quarterly revenue was up 26.1% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.500- EPS. Equities research analysts expect that Humana Inc. will post 9.66 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 24th will be paid a dividend of $0.8850 per share. The ex-dividend date of this dividend is Thursday, December 24th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.8%. Humana’s dividend payout ratio (DPR) is 34.44%.

More Humana News

Here’s some of the latest news about HUM:

  • Positive Sentiment: Royal Bank of Canada upgraded Humana to “outperform” and raised its price target, signaling greater analyst confidence in the stock. Royal Bank of Canada stock recommendations
  • Neutral Sentiment: The Humana Foundation announced nearly $14 million in grants focused on food access and social connection for seniors. This highlights community investment but has no clear near-term earnings impact. Humana Foundation Marks 45 Years With Nearly $14 Million in Grants
  • Negative Sentiment: Renewed regulatory scrutiny weighed on healthcare insurers, with Humana among the companies whose shares retreated. The articles provided do not specify the scrutiny’s details or its potential financial impact. UnitedHealth vs. Humana: Buy the Dip?

About Humana

(Free Report)

Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.